MORE►
retinal disorders
Glenn Sblendorio, chairman of the board of Nanoscope Therapeutics [Photo: Nanoscope Therapeutics, eye: Faysal Ahamed/istock; ]
Nanoscope Therapeutics Names Finance and Biotech Leader as Board Chairman
by Lance Murray | Dec 8, 2023
Splendorio's more than 30 years of experience have been marked by extensive executive leadership in the ophthalmic industry, and he will support Nanoscope in reaching its strategic vision, the company said.
by Lauren Hawkins |
Jul 21, 2020
Nanoscope Therapeutics, a TechFW client, has closed an over-subscribed Series A funding round for its leading work on retinas, which could enable the blind to see.
In addition, Nanoscope has named Al Guillem as Chairman of the Board. Guillem (pictured below) was part of TechFW's greatest success story when ZS Pharma, a company he co-founded, was purchased by AstraZeneca for $2.7 billion.
In addition, Nanoscope has named Al Guillem as Chairman of the Board. Guillem (pictured below) was part of TechFW's greatest success story when ZS Pharma, a company he co-founded, was purchased by AstraZeneca for $2.7 billion.
MORE►
